Effect of synovitis and corticosteroids on transcription of cartilage matrix proteins

American Journal of Veterinary Research

Volumn 59, Issue 8, 1998, Pages 1021-1026

  MacLeod, James N ^a   Fubini, Susan L ^a   Gu, Da Nian ^a   Tetreault, Jonathan W ^a,b   Todhunter, Rory J ^a  

^a Department of Obstetrics Gynecology   (United States)

^b SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGGRECAN; CORTICOSTEROID; FIBRONECTIN; MESSENGER RNA; METHYLPREDNISOLONE ACETATE; PROCOLLAGEN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARTILAGE CELL; CARTILAGE MATRIX; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HORSE; MALE; NONHUMAN; NORTHERN BLOTTING; PROTEIN DETERMINATION; RNA ANALYSIS; SYNOVITIS;

AGGRECANS; ANIMALS; CARTILAGE, ARTICULAR; ESCHERICHIA COLI; EXTRACELLULAR MATRIX PROTEINS; FEMALE; FIBRONECTINS; GLUCOCORTICOIDS; HORSE DISEASES; HORSES; LECTINS, C-TYPE; LIPOPOLYSACCHARIDES; MALE; METHYLPREDNISOLONE; ORCHIECTOMY; PROCOLLAGEN; PROTEOCHONDROITIN SULFATES; PROTEOGLYCANS; RNA, MESSENGER; SYNOVITIS; TRANSCRIPTION, GENETIC;

ANIMALIA; EQUIDAE; EQUUS CABALLUS;

EID: 0031904368     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. Myers SL, Brandt KD, Ehlich JW, et al. Synovial inflammation in patients with early osteoarthritis of the knee. J Rheumatol 1990;17:1662-1669.
2. Myers S, Brandt KD, O'Connor B, et al. Synovitis and osteoarthritic changes in canine articular cartilage after anterior cruciate ligament transection. Arthritis Rheum 1990;33:1406-1415.
3. Revell PA, Mayston V, Lalor P, et al. The synovial membrane in osteoarthritis: a histological study including the characterisation of the cellular infiltrate present in inflammatory osteoarthritis using monoclonal antibodies. Ann Rheum Dis 1988;47:300-307.
4. Arend WP, Dayer J-M. Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum 1990;133: 305-315.
5. Greenwald RA. Cartilage degradation in animal models of inflammatory joint disease. In: Woessner JF, Jr, Howell DS, eds. Joint cartilage degradation: basic and clinical aspects. New York: Marcel Dekker Inc, 1993;385-408.
6. Zvaifler NJ, Boyle D, Firestein GS. Early synovitis - synoviocytes and mononuclear cells. Semin Arthritis Rheum 1994;23:11-16.
7. Palmer JL, Bertone AL. Joint structure, biochemistry and biochemical disequilibrium in synovitis and equine joint disease. Equine Vet J 1994;26:263-277.
8. Pelletier J-P, Haraoui B, Martel-Pelletier J. Modulation of cartilage degradation in arthritic diseases by therapeutic agents. In: Woessner JF, Jr, Howell DS, eds. Joint cartilage degradation: basic and clinical aspects. New York: Marcel Dekker Inc. 1993;503-528.
9. Pelletier JP, Pelletier JM. Cartilage degradation by neutral proteoglycanases in experimental osteoarthrosis: suppression by steroids. Arthritis Rheum 1985;28:1393-1401.
10. Palmer JL, Bertone AL. Experimentally-induced synovitis as a model for acute synovitis in the horse. Equine Vet J 1994;26:492-495.
11. Arend WP, Joslin FG, Massoni RJ. Characteristics of chondrocyte responses to a human interleukin 1-like factor. Clin Immunol Immunopathol 1985;36:358-370.
12. Todhunter RJ, Fubini SL, Vernier-Singer M, et al. Acute synovitis and intra-articular methylprednisolone acetate in ponies. Osteoarthritis Cart 1998,6:94-105.
13. MacLeod JN, Burton-Wurster K, Gu DN, et al. Fibronectin mRNA splice variant in articular cartilage lacks bases encoding the V, III-15, and 1-10 proteins segments. J Biol Chem 1996;271:18954-18960.
14. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989.
15. Levine RA, Serdy M, Guo L, et al. Elongation factor Tu as a control gene for mRNA analysis of lung development and other differentiation and growth regulated systems. Nucleic Acids Res 1993; 21:4426.
16. Mankin HJ, Dorfman H, Lippiello L, et al. Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. J Bone Joint Surg 1971;53:523-537.
17. Eyre DR, McDevitt CA, Billingham ME, et al. Biosynthesis of collagen and other matrix proteins by articular cartilage in experimental osteoarthrosis. Biochem J 1980;188:823-837.
18. Floman Y, Eyre DR, Glimcher MJ. Induction of osteoarthrosis in the rabbit knee joint: biochemical studies on the articular cartilage. Clin Orthop 1980;147:278-286.
19. Matyas JR, Adams ME, Huang D, et al. Discoordinate gene expression of aggrecan and type II collagen in experimental osteoarthritis. Arthritis Rheum 1995;38:420-425.
20. Adams ME, Matyas JR, Huang D, et al. Expression of proteoglycans and collagen in the hypertrophic phase of experimental osteoarthritis. J Rheumatol 1995;22:94-97.
21. Dourado GS, Adams ME, Mattas JR, et al. Expression of biglycan, decorin and fibromodulin in the hypertrophic phase of experimental osteoarthritis. Osteoarthritis Cart 1996;4:187-196.
22. Galanos C, Lüderitz O, Rietschel ET, et al. Synthetic and natural Eschertchia coli free lipid A express identical endotoxin activities. Eur J Biochem 1985;145:1-5.
23. Tobias PS, Soldau K, Ulevitch RJ. Isolation of a lipopolysaccharide-binding acute phase reactant from rabbit serum. J Exp Med 1986;164:777-793.
24. Wright SD, Ramosk RA, Tobias PS, et al. CD14: a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990;249:1431-1433.
25. Raetz CRH, Ulevitch RJ, Wright SD, et al. Gram-negative endotoxin: an extraordinary lipid with profound effects on eukaryotic signal transduction. FASEB J 1991;5:2652-2660.
26. Morales TI, Hascall VC. Effects of interleukin-1 and lipopolysaccharides on protein and carbohydrate metabolism in bovine articular cartilage organ cultures. Connect Tissue Res 1989;19:255-275.
27. Chandrasekhar S, Harvey AK, Higginbotham JD, et al. Interleukin-1 induced suppression of type II collagen gene transcription involves DNA regulatory elements. Exp Cell Res 1990;191:105-114.
28. Goldring MB, Birkhead JR, Suen L-F, et al. Interleukin-1β-modulated gene expression in immortalized human chondrocytes. J Clin Invest 1994;94:2307-2316.
29. Goldring MB, Fukuo K, Birkhead JR, et al. Transcriptional suppression by interleukin-1 and interferon-γ of type II collagen gene expression in human chondrocytes. J Cell Biochem 1994;54:85-99.
30. Richardson DW, Dodge GR. Cloning of equine type II procollagen and the modulation of its expression in cultured equine articular chondrocytes. Matrix Biol 1997;16:59-64.
31. Goldring MB, Sandell LJ, Stephenson ML, et al. Immune interferon suppresses levels of procollagen mRNA and type II collagen synthesis in cultured human articular and costal chondrocytes. J Biol Chem 1986;261:9049-9056.
32. Reginato AM, Sanz-Rodriguez C, Diaz A, et al. Transcriptional modulation of cartilage-specific collagen gene expression by interferon γ and tumour necrosis factor α in cultured human chondrocytes. Biochem J 1993;294:761-769.
33. Pfeilschifter J, Bonewald L, Mundy GR. Role of growth factors in cartilage and bone metabolism. In: Sporn MB, Roberts AB, eds. Peptide growth factors and their receptors II. New York: Springer-Verlag, 1991;371-400.
34. Schneiderman R, Rosenberg N, Hiss J, et al. Concentration and size distribution of insulin-like growth factor-1 in human normal and osteoarthritic synovial fluid and cartilage. Arch Biochem Biophys 1995;324:173-188.
35. Carey DE, Liu X. Expression of bone morphogenetic protein-6 messenger RNA in bovine growth plate chondrocytes of different size. J Bone Min Res 1995;10:401-405.
36. Luyten FP. Cartilage-derived morphogenetic proteins. Key regulators in chondrocyte differentiation? Acta Orthop Scand Suppl 1995;266:51-54.
37. Hiraki Y, Inoue H, Kondo J, et al. A novel growth-promoting factor derived from fetal bovine cartilage, chondromodulin II. Purification and amino acid sequence. J Biol Chem 1996;271:22657-22662.
38. Hodges PT, Baehner FL, Masuhara K, et al. Immunolocalization of bone morphogenetic protein-4 and -6 in human growth plate. Trans 43rd Annu Meet Orthop Res Soc 1997;22:615.
39. Morales TI, Joyce ME, Sobel ME, et al. Transforming growth factor-β in calf articular cartilage organ cultures: synthesis and distribution. Arch Biochem Biophys 1991;288:397-405.
40. Burton-Wurster N, Lust G. Fibronectin in cartilage. In: Carsons SE, ed. Fibronectin in health and disease. Boca Raton, FL: CRC Press, 1989;243-254.
41. Zhang D, Burton-Wurster N, Lust G. Antibody specific for extra domain B of fibronectin demonstrates elevated levels of both extra domain B(+) and B(-) fibronectin in osteoarthritic canine cartilage. Matrix Biol 1995;14:623-633.
42. Burton-Wurster N, Lust G, MacLeod JN. Cartilage fibronectin isoforms: in search of functions for a special population of matrix glycoproteins. Matrix Biol 1997;15:441-454.
43. Schimmer BP, Parker KL. Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenocortical hormones. In: Hardman JG, Limbird LE, Molinoff PB, et al, eds. Goodman & Gilman's the pharmacological basis of therapeutics. 9th ed. New York: McGraw-Hill Book Co, 1996;1459-1485.
44. Salber RB, Gross A, Hall JH. Hydrocortisone arthropathy: an experimental investigation. Can Med J 1967;97:374-377.
45. Moskewitz RW, Davis W, Sammarco J, et al. Experimentally induced corticosteroid arthropathy. Arthritis Rheum 1970;13: 236-243.
46. Maier R, Wilhelm G. Preclinical investigations of drug effects in models of osteoarthrosis. In: Muntle E, Bjelle A, eds. Effects of drugs on osteoarthrosis, proceedings of 10th european congress of rheumatology. Moscow: Hans Huber, 1983;90-96.
47. Kalben DA. Chemical models of osteoarthritis: a pharmacological evaluation. J Rheumatol Suppl 1987;14:130-131.
48. Krook L, Maylin GA. Fractures in thoroughbred race horses. Cornell Vet Suppl 1988;78:7-133.
49. Silberberg N, Silberberg R, Hasler N. Fine structure of articular cartilage in mice receiving cortisone acetate. Arch Pathol 1966;82:569-582.
50. Mankin HF, Conger KA. The effects of intra-articular hydrocortisone on articular cartilage in rabbits. J Bone Joint Surg Am 1966;48:1383-1388.
51. Behrens F, Shepard N, Mitchell N. Metabolic recovery of articular cartilage after intra-articular injections of glucocorticoid. J Bone Joint Surg Am 1976;58:1157-1160.
52. Chunekamrai S, Krook LP, Lust G, et al. Changes in articular cartilage after injections of methyl-prednisolone acetate into equine joints. Am J Vet Res 1990;50:1733-1741.
53. Trotter GW, Mcllwraith CW, Yovich JV, et al. Effects of intra-articular administration of methylprednisolone acetate on normal equine articular cartilage. Am J Vet Res 1991;52:83-87.
54. Shoemaker RS, Bertone AL, Martin GS, et al. Effects of intra-articular administration of methylprednisolone acetate on normal articular cartilage and on healing of experimentally induced osteochondral defects in horses. Am J Vet Res 1992;53:1446-1453.
55. Thonar EJ, Lenz ME, Klintworlh GK, et al. Quantitation of keratan sulfate in blood as a marker of cartilage catabolism. Arthritis Rheum 1985;28:1367-1376.
56. Todhunter RJ, Fubini SL, Freeman KP, et al. Concentrations of keratan sulfate in plasma and synovial fluid from clinically normal horses and horses with diseased joints. J Am Vet Med Assoc 1997;210:369-374.
57. Todhunter RJ, Yeager AE, Freeman KP, et al. Keratan sulfate as a marker of articular cartilage catabolism and joint treatment in ponies. Am J Vet Res 1993;54:1007-1016.
58. Farquhar T, Todhunter RJ, Fubini SL, et al. Effect of methylprednisolone and mechanical loading on canine articular cartilage in explant culture. Osteoarthritis Cart 1996;4:55-62.
59. Gogia PP, Brown M, Al-Obaidi S. Hydrocortisone and exercise effects on articular cartilage in rats. Arch Phys Med Rehabil 1993;74:463-487.
60. Poole CA. The structure and function of articular cartilage matrices. In: Woessner JF, Jr, Howell DS, eds. Joint cartilage degradation: basic and clinical aspects. New York: Marcel Dekker Inc, 1993;1-36.
61. Eyre DR. The collagens of articular cartilage. Semin Arthritis Rheum 1991;21:2-11.
62. Eyre DR, Wu J-J. Collagen structure and cartilage matrix integrity. J Rheumatol Suppl 1995;22:82-85.
63. Pelletier J-P, Mineau F, Raynauld J-P, et al. Intraarticular injections with methylprednisolone acetate reduce osteoarthritic lesions in parallel with chondrocyte stromelysin synthesis in experimental Osteoarthritis. Arthritis Rheum 1994;37:414-423.
64. Jee WS, Li XJ, Ke HZ, et al. Application of computer-based histomorphometry to the quantitative analysis of methylprednisolone-treated adjuvant arthritis in rats. Bone Miner 1993;22:221-247.
65. Poland JW, McIlwraith CW, Trotter GW, et al. Effect of betamethasone and exercise on equine carpal joints with osteochondral fragment. Vet Surg 1994;23:369-376.
66. van der Kraan PM, Vitters EL, Postma NS, et al. Maintenance of the synthesis of large proteoglycans in anatomically intact murine articular cartilage by steroids and insulin-like growth factor I. Ann Rheum Dis 1993;52:734-741.
67. DiBattista JA, Martel-Pelletier J, Antakly T, et al. Reduced expression of glucocorticoid receptor levels in human osteoarthritic chondrocytes. Role in the suppression of metalloprotease synthesis. J Clin Endocrinol Metabol 1992;76:1128-1134.